doxorubicin
Showing 1 - 25 of 426
Solid Tumor, KRAS Mutation-Related Tumors Trial in Washington (NEROFE, Doxorubicin)
Recruiting
- Solid Tumor
- KRAS Mutation-Related Tumors
- NEROFE
- Doxorubicin
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023
Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)
Not yet recruiting
- Breast Cancer
- Nanoxel M
- +3 more
- (no location specified)
Jan 20, 2022
Sarcoma Trial in Boston (Bevacizumab, Doxorubicin, Radiation Therapy)
Active, not recruiting
- Sarcoma
- Bevacizumab
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Apr 6, 2022
Advanced Soft-tissue Sarcoma Trial in Nicosia, Amman (Doxorubicin, Cyclophosphamide Oral Product, Prednisolone)
Recruiting
- Advanced Soft-tissue Sarcoma
- Doxorubicin
- +3 more
-
Nicosia, Cyprus
- +1 more
Jul 1, 2022
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Advanced Leiomyosarcoma Trial in Boston (Lurbinectedin,
Recruiting
- Advanced Soft-tissue Sarcoma
- +3 more
- Lurbinectedin
- Doxorubicin
-
Boston, Massachusetts
- +1 more
Feb 14, 2022
Brain Tumor Trial in Washington (Exablate, Doxorubicin)
Recruiting
- Brain Tumor
- Exablate
- Doxorubicin
-
Washington, District of ColumbiaChildren's National Medical Center
Jan 4, 2023
Brain Tumor Trial in Toronto (Exablate, Doxorubicin)
Recruiting
- Brain Tumor
- Exablate
- Doxorubicin
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jan 5, 2023
Soft Tissue Sarcoma Trial in Worldwide (Onfekafusp alfa, Doxorubicin)
Recruiting
- Soft Tissue Sarcoma
- Onfekafusp alfa
- Doxorubicin
-
Bad Saarow, Germany
- +8 more
Apr 8, 2022
Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, ALX148, Doxorubicin)
Not yet recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 19, 2022
Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma
Active, not recruiting
- Soft Tissue Sarcoma
- Doxil
- Doxorubicin
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 24, 2022
Uterine or Soft Tissue Leiomyosarcoma Trial in Villejuif (Doxorubicin, Trabectedin)
Completed
- Uterine or Soft Tissue Leiomyosarcoma
- Doxorubicin
- Trabectedin
-
Villejuif, Val De Marne, FranceGustave Roussy
Dec 10, 2021
Soft Tissue Sarcoma Trial in Toronto (Selinexor, Doxorubicin)
Completed
- Soft Tissue Sarcoma
- Selinexor
- Doxorubicin
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Nov 26, 2021
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV, Pancreatic Cancer Non-resectable Trial in Oxford (Focused
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Focused Ultrasound
- +2 more
-
Oxford, United KingdomOxford University Hospitals NHS Trust
Feb 22, 2022
Soft Tissue Sarcoma Trial in New York (Doxorubicin, APX005M)
Recruiting
- Soft Tissue Sarcoma
- Doxorubicin
- APX005M
-
New York, New YorkColumbia University Medical Center
Nov 12, 2021
Pancreas Cancer Trial in Scottsdale, Morristown, Milwaukee (L-DOS47, Doxorubicin)
Recruiting
- Pancreas Cancer
- L-DOS47
- Doxorubicin
-
Scottsdale, Arizona
- +2 more
Mar 16, 2022
Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)
Active, not recruiting
- Solid Tumor
- Urethral Cancer
- Bortezomib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 21, 2022
Advanced Solid Tumors Amenable to Anthracycline Therapy, Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer
Completed
- Advanced Solid Tumors Amenable to Anthracycline Therapy
- Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
- L19TNFα
- Doxorubicin
-
Münster, Germany
- +1 more
Apr 1, 2022
Leiomyosarcoma Trial in United States (Doxorubicin, L19TNF plus doxorubicin)
Recruiting
- Leiomyosarcoma
- Doxorubicin
- L19TNF plus doxorubicin
-
Phoenix, Arizona
- +7 more
Apr 7, 2022
Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by
Not yet recruiting
- Adult T-cell Leukemia/Lymphoma
- +4 more
- CC-486 (5-azacitidine)
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Bintrafusp alfa, Doxorubicin)
Recruiting
- Advanced Soft-tissue Sarcoma
- Metastatic Soft-tissue Sarcoma
- Bintrafusp alfa
- Doxorubicin
-
Bordeaux, France
- +7 more
Dec 6, 2021
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)
Recruiting
- Advanced Soft-tissue Sarcoma
- Metastatic Soft-tissue Sarcoma
- Doxorubicin
- Cyclophosphamide
-
Toulouse, FranceInstitut Claudius Reagaud-IUCT Oncopôle
Sep 27, 2021
Triple Negative Breast Cancer Trial in Chicago (Carboplatin, Paclitaxel, Doxorubicin)
Active, not recruiting
- Triple Negative Breast Cancer
- Carboplatin
- +3 more
-
Chicago, IllinoisUniversity of Illinois
Jan 28, 2022